본문 바로가기
KERD
논문KCI 등재

Validation of the Eighth American Joint Committee on Cancer Staging System for Distal Bile Duct Carcinoma

3

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose T category of the eighth edition of the American Joint Committee on Cancer (AJCC) staging system for distal bile duct carcinoma (DBDC) was changed to include tumor invasion depth measurement, while the N category adopted a 3-tier classification system based on the number of metastatic nodes. Materials and Methods To validate cancer staging, a total of 200 surgically resected DBDCs were staged and compared according to the seventh and eighth editions. Results T categories included T1 (n=37, 18.5%), T2 (n=114, 57.0%), and T3 (n=49, 24.5%). N categories included N0 (n=133, 66.5%), N1 (n=50, 25.0%), and N2 (n=17, 8.5%). Stage groupings included I (n=33, 16.5%), II (n=150, 75.0%), and III (n=17, 8.5%). The overall 5-year survival rates (5-YSRs) of T1, T2, and T3 were 59.3%, 42.4%, and 12.2%, respectively. T category could discriminate patient survival by both pairwise (T1 and T2, p=0.011; T2 and T3, p < 0.001) and overall (p < 0.001) comparisons. The overall 5-YSRs of N0, N1, and N2 were 47.3%, 17.0%, and 14.7%, respectively. N category could partly discriminate patient survival by both pairwise (N0 and N1, p < 0.001; N1 and N2, p=0.579) and overall (p < 0.001) comparisons. The overall 5-YSRs of stages I, II, and III were 59.0%, 35.4%, and 14.7%, respectively. Stages could distinguish patient survival by both pairwise (I and II, p=0.002; II and III, p=0.015) and overall (p < 0.001) comparisons. On multivariate analyses, T and N categories (p=0.014 and p=0.029) and pancreatic invasion (p=0.006) remained significant prognostic factors. Conclusion The T and N categories of the eighth edition AJCC staging system for DBDC accurately predict patient prognosis.

Abstract

Purpose T category of the eighth edition of the American Joint Committee on Cancer (AJCC) staging system for distal bile duct carcinoma (DBDC) was changed to include tumor invasion depth measurement, while the N category adopted a 3-tier classification system based on the number of metastatic nodes. Materials and Methods To validate cancer staging, a total of 200 surgically resected DBDCs were staged and compared according to the seventh and eighth editions. Results T categories included T1 (n=37, 18.5%), T2 (n=114, 57.0%), and T3 (n=49, 24.5%). N categories included N0 (n=133, 66.5%), N1 (n=50, 25.0%), and N2 (n=17, 8.5%). Stage groupings included I (n=33, 16.5%), II (n=150, 75.0%), and III (n=17, 8.5%). The overall 5-year survival rates (5-YSRs) of T1, T2, and T3 were 59.3%, 42.4%, and 12.2%, respectively. T category could discriminate patient survival by both pairwise (T1 and T2, p=0.011; T2 and T3, p < 0.001) and overall (p < 0.001) comparisons. The overall 5-YSRs of N0, N1, and N2 were 47.3%, 17.0%, and 14.7%, respectively. N category could partly discriminate patient survival by both pairwise (N0 and N1, p < 0.001; N1 and N2, p=0.579) and overall (p < 0.001) comparisons. The overall 5-YSRs of stages I, II, and III were 59.0%, 35.4%, and 14.7%, respectively. Stages could distinguish patient survival by both pairwise (I and II, p=0.002; II and III, p=0.015) and overall (p < 0.001) comparisons. On multivariate analyses, T and N categories (p=0.014 and p=0.029) and pancreatic invasion (p=0.006) remained significant prognostic factors. Conclusion The T and N categories of the eighth edition AJCC staging system for DBDC accurately predict patient prognosis.

참고문헌 (25)

  1. Gonzalez RS, "Intrapancreatic distal common bile duct carcinoma : analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas", Mod Pathol, 29, pp.1358~1369 (2016)
  2. Shin HR, "Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma : focus on East and South-Eastern Asia", Asian Pac J Cancer Prev, 11, pp.1159~1166 (2010)
  3. Albores-Saavedra J, "WHO classification of tumours of digestive system", pp.266~273 (2010), IARC Press
  4. Siegel RL, "Cancer statistics, 2015", CA Cancer J Clin, 65, pp.5~29 (2015)
  5. Beahrs OH, "American Joint Committee in Cancer. Manual for staging of cancer" (1992), J.B. Lippincott Company
  6. Fleming ID, "AJCC cancer staging manual" (1997), Lippincott-Raven
  7. Hong SM, "Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients", Cancer, 104, pp.802~810 (2005)
  8. Hong SM, "Reconsideration of the histologic definitions used in the pathologic staging of extrahepatic bile duct carcinoma", Am J Surg Pathol, 30, pp.744~749 (2006)
  9. Hong SM, "Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma", Surgery, 146, pp.250~257 (2009)
  10. Edge SB, "AJCC cancer staging manual" (2010), Springer-Verlag
  11. Greene FL, "AJCC cancer staging manual" (2002), Springer-Verlag
  12. Hong SM, "Measurement of the invasion depth of extrahepatic bile duct carcinoma: an alternative method overcoming the current T classification problems of the AJCC staging system", Am J Surg Pathol, 31, pp.199~206 (2007)
  13. Moon A, "Validation of T stage according to depth of invasion and N stage subclassification based on number of metastatic lymph nodes for distal extrahepatic bile duct (EBD) carcinoma", Medicine (Baltimore), 94, pp.e2064~ (2015)
  14. Edge SB, "AJCC cancer staging manual" (2017), Springer Nature
  15. Yoshida T, "Para-aortic lymph node metastasis in carcinoma of the distal bile duct", Hepatogastroenterology, 45, pp.2388~2391 (1998)
  16. Yoshida T, "The pattern of lymphatic spread in carcinoma of the distal bile duct", Int Surg, 83, pp.124~127 (1998)
  17. Yoshida T, "Patterns of lymph node metastasis in carcinoma of the distal bile duct", Hepatogastroenterology, 46, pp.1595~1598 (1999)
  18. Yoshida T, "Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer", Arch Surg, 137, pp.69~73 (2002)
  19. Yoshida T, "Lymphatic spread differs according to tumor location in extrahepatic bile duct cancer", Hepatogastroenterology, 50, pp.17~20 (2003)
  20. Yoshida T, "Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma", Am J Surg, 187, pp.736~740 (2004)
  21. Schwarz RE, "Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. population data", J Gastrointest Surg, 11, pp.158~165 (2007)
  22. Hong SM, "The number of metastatic lymph nodes in extrahepatic bile duct carcinoma as a prognostic factor", Am J Surg Pathol, 29, pp.1177~1183 (2005)
  23. Kiriyama M, "Prognostic impact of lymph node metastasis in distal cholangiocarcinoma", Br J Surg, 102, pp.399~406 (2015)
  24. Hamilton SR, "WHO classification of tumours of the digestive system", pp.134~146 (2010), IARC Press
  25. Kang JS, "Prognostic predictability of the new American Joint Committee on Cancer 8th staging system for distal bile duct cancer : limited usefulness compared with the 7th staging system", J Hepatobiliary Pancreat Sci, 25, pp.124~130 (2018)

관련 논문AI추천

Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma: Limited Improvement Compared with the 7th Staging System권재우, 김송철, 박예종, 송기병, 이우형, 이재훈, 이종우, 황대욱대한암학회 · Cancer Research and Treatment2020 · 제52권 제3호Validation of the 8th Edition of the American Joint Committee on Cancer Staging System for Gallbladder Cancer and Implications for the Follow-up of Patients without Node Dissection황신, 성유나, 송기병, 송민정, 안철수, 이재훈, 홍승모, 황대욱대한암학회 · Cancer Research and Treatment2020 · 제52권 제2호Stage Evaluation of Cystic Duct Cancer황신, 김예슬, 성유나, 유대광, 이경진, 이우형, 전선영, 정해성, 조형준, 홍승모대한암학회 · Cancer Research and Treatment2025 · 제57권 제2호Proximal Resection Margins: More Prognostic than Distal Resection Margins in Patients Undergoing Hilar Cholangiocarcinoma Resection김성훈, 김태현, 박상재, 우상명, 유태석, 이순애, 이승덕, 이우진, 한성식, 홍은경대한암학회 · Cancer Research and Treatment2018 · 제50권 제4호Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients김경식, 박경란, 박준성, 성진실, 윤동섭, 이우정, 이익재, 임정호대한암학회 · Cancer Research and Treatment2016 · 제48권 제2호Risk Factors for Distant Metastasis in Extrahepatic Bile Duct Cancer after Curative Resection (KROG 1814)김규보, 김병혁, 김우철, 김진희, 김태규, 김태현, 박영희, 박혜진, 성진실, 신현수, 유정일, 임정호, 장아람, 정배권, 정원근, 지의규, 최진화대한암학회 · Cancer Research and Treatment2024 · 제56권 제1호

이 간행물의 다른 논문 (39건)

S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial김봉석, 장대영, 라선영, 김기향, 강석윤, 이문희, 정현철, 정민규, 형우진, 이충근, 김효송, 정재호, 신동복, 정인경, 이경희, 노성훈pp. 1-11The Effect of Hospital Case Volume on Clinical Outcomes in Patients with Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Analysis (KROG-1106)김진호, 노재명, 이종훈, 김성환, 최진화, 김연실, 김원택, 오영택, 강민규, 김진희, 조관호, 이창걸, 김지윤, 문성호, 조문준, 안용찬, 금기창, 우홍균, 오동률, 하보람, 계철승pp. 12-23Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma김명진, 최진영, 박미숙, 이진용, 한경화, 강창무, 정용은, 김혜진pp. 24-33The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy EraSi-Yang Wang, Dong-Mei Mai, Yu-Yun Du, Dong-Hua Luo, Hao-Yuan Mo, Wang-Jian Zhang, Wayne R. Lawrence, Ya-Nan Jin, Xiu-Yu Cai, Mei-Su Lipp. 34-42Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)손주혁, 정경해, 박연희, 이경훈, 김태용, 박인혜, 이수이, 임석아, 노정실, 박경화, 김지현, 심성훈, 이근석, 안진희, 김성배, 남병호, 김희준pp. 43-52